Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate
about
Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprosthesesCollagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical SubstratesHydrolysis of triple-helical collagen peptide models by matrix metalloproteinasesHomophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.TIMP-2 is required for efficient activation of proMMP-2 in vivoCharacterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertasesOptimization of total protein and activity assays for the detection of MMP-12 in induced human sputum.The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.Engineered sarafotoxins as tissue inhibitor of metalloproteinases-like matrix metalloproteinase inhibitors.High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.Engineering of selective TIMPs.The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.Hepatocyte produced matrix metalloproteinases are regulated by CD147 in liver fibrogenesisActive matrix metalloproteinase-2 activity discriminates colonic mucosa, adenomas with and without high-grade dysplasia, and cancers.Exosite interactions impact matrix metalloproteinase collagen specificities.Expression of matrix metalloprotease-2-cleaved laminin-5 in breast remodeling stimulated by sex steroids.The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli.Triple-helical transition state analogues: a new class of selective matrix metalloproteinase inhibitors.Functional proteomic analysis of seminal plasma proteins in men with various semen parametersDifferentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.Active MMP-2 effectively identifies the presence of colorectal cancer.KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species.Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment.Selective modulation of matrix metalloproteinase 9 (MMP-9) functions via exosite inhibition.The isolation, characterization, and molecular cloning of a 75-kDa gelatinase B-like enzyme, a member of the matrix metalloproteinase (MMP) family. An avian enzyme that is MMP-9-like in its cell expression pattern but diverges from mammalian gelatinComparative analysis of the noncollagenous NC1 domain of type IV collagen: identification of structural features important for assembly, function, and pathogenesis.Involvement of a region near valine-69 of tissue inhibitor of metalloproteinases (TIMP)-1 in the interaction with matrix metalloproteinase 3 (stromelysin 1).Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion.Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis.Proteolytic imbalance is reversed after therapeutic surgery in breast cancer patients.Invasiveness of breast cancer cells MDA-MB-231 through extracellular matrix is increased by the estradiol metabolite 4-hydroxyestradiol.Effect of flavones on rat brain and lung matrix metalloproteinase activity measured by film in-situ zymography.Inhibition of matrix metalloproteinase activity by ACE inhibitors prevents left ventricular remodeling in a rat model of heart failure.Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells.Matrix-assisted refolding, purification and activity assessment using a 'form invariant' assay for matrix metalloproteinase 2 (MMP2).Stimulation of angiogenesis through cathepsin B inactivation of the tissue inhibitors of matrix metalloproteinasesExpression of matrix metalloproteinases in the subretinal fluid correlates with the extent of rhegmatogenous retinal detachment
P2860
Q24338121-EEF40CEA-730F-4B52-BA77-AF68108A3018Q27301783-4D794B38-20E5-498C-9AA3-98FF6A2DA3F2Q28143236-E855C135-51EE-4560-B393-4122F966593AQ28215016-3C65A41C-130B-41C5-9F06-D7D8909C2D94Q28512714-BC69CFFA-1A52-44EA-B41A-A8E27ACD64B9Q28619008-AA6D73BA-FD5D-4C78-916C-A5BCD6A5819AQ30986676-EEBBA010-A31D-40AA-ABC0-5CAC99832B88Q33261566-3F6C5E02-D148-4A42-96C6-3EFA11686DE6Q33290604-8783A13B-A199-47FF-843F-AC06F54685CEQ33325058-D55E88CD-FBDB-484F-88FE-DAE47D817720Q33692887-EA747912-A9DF-4978-BE42-82D880340049Q33715032-2DE15B9F-CFC0-4A1C-8D48-09600384A60AQ33886514-67BFFFE0-266C-4180-97E3-97E7185FA15FQ33976028-A4AC97B8-BBB0-4FA6-BF59-D18EEA25504FQ34711492-AA2AD172-75C0-43DA-9764-3E5D2F832B7CQ35423858-A59A2698-0848-4514-B457-AA1395101D42Q35786809-F79DF7D9-A4A6-4EBB-B784-DDDDE09793E9Q36079853-1EA1522D-1F9B-4033-A440-09179B10C0BBQ36292014-E3217657-63AD-40C6-890F-62A04FC5737FQ36865326-8C688BCF-CDFA-4C68-88DF-3107D7F60220Q36901061-74DA2177-0EF6-4855-8A96-AA49D81AD3ACQ36942459-8145F5A9-9C1B-4495-83D0-15A32E92848BQ37415978-E7887139-DB43-4572-B2BC-408F795F5423Q37716380-62DE4B60-711F-4D88-85A2-C34B5F0BCFACQ38233004-CEDCC4F1-13E4-492C-9220-B75F5838607BQ40089357-189A97B8-5043-4928-A6B0-94E56C247879Q40852124-5B21278A-563D-44A6-87F7-934D82FCE6E3Q41854234-C3278BFE-4844-4789-B72B-2B4191E2177EQ41970870-58024340-DBC2-48C0-AD06-8B4CDE43EF26Q42279993-B6C7705D-CE4A-4315-BF29-9F4A538F7AB9Q43576596-E4B86725-9916-4C52-875A-79C3C2874172Q43765113-25072AEF-A82F-4E4D-A88E-06FE23E37AB7Q44785987-4CFE2D7C-D0E2-405E-9FD8-9C59C05D5721Q45119898-2C2D4F1B-33EE-4162-9898-968F343BB1C2Q46438454-71A534E0-3D9D-4160-BE5A-846C4EA42068Q51994063-0AF9A7AA-EC6A-4E28-A886-A5BB517DDEA7Q52193484-5C2E519C-EE30-4D95-BECA-3C7FC9EB7AE4Q53474394-40A211DA-AF24-480C-B914-A48DE53C98BCQ57696102-3DC78C08-95B4-47F8-B3C7-35E0DE71D84AQ58217653-1B1BDBAC-C856-4439-B1D1-F421E899F592
P2860
Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Steps involved in activation o ...... 4-aminophenylmercuric acetate
@en
Steps involved in activation of the complex of pro-matrix metalloproteinase 2
@nl
type
label
Steps involved in activation o ...... 4-aminophenylmercuric acetate
@en
Steps involved in activation of the complex of pro-matrix metalloproteinase 2
@nl
prefLabel
Steps involved in activation o ...... 4-aminophenylmercuric acetate
@en
Steps involved in activation of the complex of pro-matrix metalloproteinase 2
@nl
P2860
P356
P1433
P1476
Steps involved in activation o ...... 4-aminophenylmercuric acetate
@en
P2093
P2860
P304
P356
10.1042/BJ3080645
P407
P478
308 ( Pt 2)
P577
1995-06-01T00:00:00Z